Clinical Trials Logo

Clinical Trial Summary

The primary purpose is to evaluate the impact of hypnosis coupled with MEOPA (Equimolar Mix-ture of Nitrogen Protoxide and Oxygen) on patient comfort when performing transoesophageal echocardiographies. Further studies on the use of MEOPA alone or the technique of hypnosis alone in the context of an TEE, would not be innovative in any way in view of previous studies or already in progress. However, service has led to perform TEEs several times by combining MEOPA and hypnosis. Doctors noted a clear reduction in induction time for hypnosis and satisfaction of the patient and operators. This association technique is very often used in pediatrics. According to one study, it seems that MEOPA increases the threshold of suggestibility and imagination. However suggestion and imagination are two essential notions of the hypnotic technique. To date, doctors have not found any other studies combining MEOPA and hypnosis for adults patients in the context of TEE. This leads to the following hypothesis: Is there a difference for the patient in terms of for the global management of pain and anxiety between an TEE performed under MEOPA with a standard support and TEE under MEOPA coupled with hypnosis with support standard? Secondary purposes are: 1. Compare patients' feelings / opinions: patients who have benefited from hypnosis associated with MEOPA versus patients who have been treated with MEOPA alone. 2. Compare patient stress: patients who have benefited from hypnosis associated with MEOPA versus patients who have benefited from MEOPA alone. 3. Compare the operators' feelings / opinions: procedures that have been performed under hypno-analgesia and MEOPA versus standard procedures under MEOPA alone. 4. Failed the TEE procedure


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT04398017
Study type Interventional
Source University Hospital, Strasbourg, France
Contact
Status Terminated
Phase N/A
Start date October 14, 2020
Completion date August 12, 2022

See also
  Status Clinical Trial Phase
Terminated NCT00176657 - The Use of HEMOBAG to Salvage Blood After Cardiac Surgery Phase 2
Completed NCT00027001 - Qigong Therapy For Heart Device Patients N/A
Completed NCT00661752 - Protocol for Evaluation of Quarter-Time Cardiac Imaging: 5-Minutes Rest and 3-Minutes Stress Wide Beam Reconstruction (WBR) Versus Full-Time Filtered Back Projection (FBP) N/A
Completed NCT00296738 - 123I-MIBG SPECT/CT for Assessment of Cardiac Sympathetic Innervation Phase 0
Completed NCT00293592 - Dexamethasone for Cardiac Surgery Trial N/A
Completed NCT01080781 - Ephrin B1 Regulation in Human Right Appendage N/A
Completed NCT00011310 - Cardiopulmonary Effects of Particulate Exposure N/A
Completed NCT02727634 - Ultrapower; a Minimally Invasive Tool for Evaluation of Total Cardiac Power N/A
Completed NCT01639313 - Comparison of Nexfin Pulse Contour Analysis and Cardiac Magnetic Resonance Imaging for the Measurement of Cardiac Output N/A
Completed NCT00945048 - Non-Invasive Determination of Cardiac Output by Electrical Velocimetry N/A
Completed NCT00281424 - Increasing Walking Following Cardiac Rehabilitation Phase 2/Phase 3
Not yet recruiting NCT06409481 - Pharmacovigilance Assessment of Reporting of Cardiovascular Adverse Events With Antineoplastic Agents (PARCA)
Completed NCT02723890 - The Efficacy and Safety of Using the Novel Tyto Device N/A
Completed NCT01165515 - Endostatin Serum Levels During Bicycle Stress Test N/A
Recruiting NCT05051254 - Respiratory Muscles and Work of Breathing in Children N/A
Completed NCT01683448 - The Effect of Perioperative Medications on the Outcomes of Patients Undergoing Cardiac Surgery
Terminated NCT00229892 - Incisions for Cardiac Surgery N/A
Completed NCT02802254 - Increasing Risk Perception of Physical Activity Using Patient-targeted Feedback. Phase 2/Phase 3
Completed NCT02159014 - DanceFit Prime: A Dance Based Physical Activity and Nutritional Intervention for Primary Care - A Feasibility Study N/A
Completed NCT00479804 - Non-Invasive Determination of Cardiac Output by Inertgas Rebreathing Method N/A